# Sven Bakkes

> Sven Bakkes is a seed investor at LUMO labs backing Health Care. See 21 investments, check sizes, portfolio and contact details. Updated Aug 2026.

- Type: Angel Investor
- Fund: [LUMO labs](https://shizune.co/investors/profile/lumo-labs)
- Location: Eindhoven, The Netherlands
- Total investments: 21
- Last investment: Apr 2026
- Lead investor: 62%
- Last updated: Aug 2026
- LinkedIn: https://www.linkedin.com/in/svenbakkes/details/experience/
- Facebook: https://www.facebook.com/sven.bakkes

Sven Bakkes is a seed investor at LUMO labs in Eindhoven focused on Health Care and Artificial Intelligence. Sven Bakkes is based out of Eindhoven, North Brabant and is the Founding Partner of LUMO labs. Sven previously worked at Prins Alternative Fuel Systems as a Sales Manager. Sven Bakkes attended the Maastricht University. Sven Bakkes has received Automechanika Innovation Award, Winner Innovation Award (Aachen Germany) 2008 in their career.

## Contacts

5 contacts available for Sven Bakkes: work email, personal email, work phone, personal phone and socials. Sign up free to unlock them: https://app.shizune.co/sign-up/investor-profiles/find-email/sven-bakkes?utm_source=investor_profile

## Investment focus

### Industry

| Industry | Investments | Share |
| --- | --- | --- |
| Health Care | 6 | 29% |
| Artificial Intelligence | 6 | 29% |
| Software | 5 | 24% |
| Medical Device | 3 | 14% |
| Health Diagnostics | 3 | 14% |

25 industries tracked in total.

### Stage

| Stage | Investments | Share |
| --- | --- | --- |
| Seed | 10 | 48% |
| Pre-Seed | 5 | 24% |
| Venture - Series Unknown | 3 | 14% |
| Series A | 2 | 10% |

### Country

| Country | Investments | Share |
| --- | --- | --- |
| The Netherlands | 10 | 48% |
| Germany | 3 | 14% |
| Spain | 2 | 10% |
| Belgium | 1 | 5% |

## Investments

| Company | Description | Amount | Stage | Date | Website |
| --- | --- | --- | --- | --- | --- |
| AirHub | AirHub is a software company that provides tools, training, software, and support for drone operations management. | $5.1M | Series A | Apr 08, 2026 |  |
| Aiosyn | Aiosyn uses artificial intelligence to develop pathology algorithms to improve the precision of diagnostics in cancer and chronic kidney diseases. The company uses a modular SaaS model to integrate its algorithms with existing pathology workflows. At the same time it leverages its algorithms and AI capabilities to improve the efficiency of cancerand CKD drug development studies for biopharma. | $2.8M | Seed | Sep 09, 2025 |  |
| Nuclivision | Nuclivision provides novel radiotracers and treatments for oncology that develop AI-driven solutions to help patients by improving the quality, safety, and accessibility of nuclear medicine. | $5.7M | Seed | Apr 24, 2025 |  |
| Surgical Reality | Surgical Reality, a startup in the medical imaging field, converts conventional CT scans into intricate, interactive 3D models. This advancement provides surgeons with enhanced insights into patient anatomy, facilitating improved surgical planning and increasing the likelihood of successful operations. |  | Venture - Series Unknown | Feb 13, 2025 |  |
| Sycai Technologies | Sycai Technologies provides detect pancreatic cystic lesions, diagnosis, pancreatic cysts, software mask, assure patient data protection, and disruptive radiology assistant services. | $3.1M | Series A | Jan 23, 2025 |  |
| Scenexus | Scenexus is a startup that offers enterprise software for urban development. |  | Pre-Seed | Jan 15, 2025 |  |
| Scenexus | Scenexus is a startup that offers enterprise software for urban development. | $1.6M | Seed | Jan 15, 2025 |  |
| AirHub | AirHub is a software company that provides tools, training, software, and support for drone operations management. | $1.1M | Venture - Series Unknown | Apr 16, 2024 |  |
| Enatom | Enatom specializes in advanced 3D visualization for human anatomy teaching. | $965.3K | Pre-Seed | Apr 11, 2024 |  |
| Whispp | Worldwide 300 million people suffer from a voice disability or stutter severely. It has a major impact on their daily lives, work and sense of happiness. They also can’t make intelligible and relaxed phone and video calls. With Whispp they can!Whispp’s Assistive Voice Technology and Calling App convert whispered speech (people who stutterseverely speak relaxed while whispering) and vocal cord-impaired speech (throat cancer, vocal cord paralysis, ALS) into a person’s natural voice, in real-time. For non-patient users, Whispp enables silent phone and video calls with more privacy and not disturbing the people around you. | $819.9K | Seed | Jan 09, 2024 |  |

10 of 21 investments shown.

## Co-investors
- [OostNL](https://shizune.co/investors/profile/oostnl) — VC Fund, 3 deals together
- [Bayern Kapital](https://shizune.co/investors/profile/bayern-kapital) — VC Fund, 2 deals together
- [Cross Atlantic Angels](https://shizune.co/investors/profile/cross-atlantic-angels) — VC Fund, 2 deals together
- [Elaia](https://shizune.co/investors/profile/elaia-partners) — VC Fund, 2 deals together
- [Health Innovations](https://shizune.co/investors/profile/health-innovations) — VC Fund, 2 deals together
- Lumaux — VC Fund, 2 deals together

## About LUMO labs

VC Fund · Eindhoven, The Netherlands

LUMO Labs is an impact-driven multi-stage (pre-seed through series A) capital fund with a two-year growth program for founding teams of ventures focused on AI/Data, Blockchain, IoT, VR/AR and Security. We believe these emerging technologies hold the key to solving the social challenges people face today. At LUMO Labs, we focus onsustainable cities and communities, health and wellbeing and quality education. We create opportunities for people and emerging technologies by connecting impact-driven groundbreaking start-ups to our funds, our expertise, our network and each other.

5 contacts available at LUMO labs.

| Name | Title | Profile |
| --- | --- | --- |
| Andy Lürling | Founder | — |
| Sven Bakkes | Founding Partner | — |
| Dagmar van Ravenswaay Claasen | Partner | — |
| Jorge Blasco | Venture partner | — |
| Linn-Cecilie Linnemann | Partner | — |

## Similar investors

### Similar stage
- [Antler](https://shizune.co/investors/profile/antler-be9c) — VC Fund
- [Alumni Ventures](https://shizune.co/investors/profile/alumni-ventures-group) — VC Fund
- [Right Side Capital Management](https://shizune.co/investors/profile/right-side-capital-management) — VC Fund

## FAQ

### What does Sven Bakkes invest in?

Sven Bakkes invests primarily in Health Care, Artificial Intelligence and Software startups, most often at Seed and Pre-Seed stage. Most of the 21 investments tracked by Shizune back companies in The Netherlands. The Investment Focus section breaks down every industry, stage and country in the portfolio.

### How do I contact Sven Bakkes?

Public channels for Sven Bakkes include LinkedIn and Facebook. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.

### When did Sven Bakkes last invest?

The most recent investment recorded for Sven Bakkes closed in Apr 2026. Shizune tracks 21 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.

### Is Shizune's investor data accurate?

Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.

# About Shizune
Shizune.co is an investor database. Core features:
- 48,091 startup investors (angels, VCs, accelerators, and others)
- Email, phone, LinkedIn (for intros), socials, and other contact data
- Updated daily from public funding news
- CSV and Excel export

The User can access the full database FOR FREE after signing up: shizune.co